WallStreetZenWallStreetZen
Analyst Ranking
Top 5%
#226 out of 4587 analysts
Average Return
+17.38%
Win Rate
69%61 out of 88
Risk vs Reward
Poor
Good

Catherine Schulte's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanostring Technologies IncNSTGQ
+172.99%$25.14$68.63
2020-04-06 -
2021-04-07
Buy
Exact Sciences CorpEXAS
+117.49%$44.37$96.50
2018-02-26 -
2019-02-27
Buy
Castle Biosciences IncCSTL
+112.13%$28.27$59.97
2020-03-26 -
2021-03-26
Buy
Nanostring Technologies IncNSTGQ
+106.07%$14.00$28.85
2018-06-03 -
2019-06-04
Buy
Nanostring Technologies IncNSTGQ
+96.15%$7.79$15.28
2017-11-02 -
2018-11-02
Buy

Catherine Schulte Analyst Color

Get additional color on Catherine Schulte's coverage of popular stocks

Catherine Schulte's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Mettler Toledo International IncMTD
5Hold$1,360.00-10.69%Maintains
7 days ago
Maravai Lifesciences Holdings IncMRVI
3Buy$10.00-11.66%Maintains
12 days ago
Bio Techne CorpTECH
7Buy$81.00-3.35%Maintains
18 days ago
Avantor IncAVTR
8Buy$26.00+4.04%Maintains
22 days ago
Thermo Fisher Scientific IncTMO
20Buy$620.00+4.15%Maintains
a month ago
Danaher CorpDHR
4Buy$271.00+1.96%Maintains
a month ago
Agilent Technologies IncA
11Buy$130.00-15.71%Maintains
6 months ago
Qiagen NvQGEN
1Buy$51.50+12.72%Initiates Coverage On
8 months ago
Exact Sciences CorpEXAS
10Buy$121.00+140.17%Maintains
10 months ago
Revvity IncRVTY
5Buy$165.00N/AMaintains
a year ago
Castle Biosciences IncCSTL
4Buy$38.00N/AMaintains
a year ago
Twist Bioscience CorpTWST
2Buy$33.00N/AMaintains
a year ago
Biora Therapeutics IncBIOR
1Hold$2.00N/ADowngrades
3 years ago
Chembio Diagnostics IncCEMI
1Buy$21.00N/AInitiates Coverage On
4 years ago
Illumina IncILMN
4Hold$310.00N/ADowngrades
4 years ago
Nanostring Technologies IncNSTGQ
5Buy$29.00N/AMaintains
4 years ago
Waters CorpWAT
5Hold$211.00N/ADowngrades
5 years ago
Natera IncNTRA
1Buy$20.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.